Enacademic πŸŽ“Analogindex
49 subscribers
77.3K photos
5 videos
249K links
Download Telegram
*ΠŸΠΎΠ΄ΠΊΠ°ΡΡ‚ Β«ΠŸΠΎΠ²Π°Ρ€ Π²Π°Ρ€ΠΈΡ‚ Ρ‚ΠΈΒ»: task β€” Π·Π°Π΄Π°Ρ‡Π°, salary β€” Π·Π°Ρ€ΠΏΠ»Π°Ρ‚Π°, break β€” ΠΏΠ΅Ρ€Π΅Ρ€Ρ‹Π²*

Π’ этом эпизодС Π·Π°ΠΏΠΎΠΌΠ½ΠΈΡ‚ΡŒ Π½ΠΎΠ²Ρ‹Π΅ слова ΠΏΠΎΠΌΠΎΠ³ΡƒΡ‚ стаТёр, солярий ΠΈ Ρ‚Π°Π½Ρ†Ρ‹.
[Read more...](https://lifehacker.ru/povar-varit-ti-76/)
*UAW rejects pay deal with Mack Trucks as Big 3 strike enter fourth week*

United Autoworkers Union members voted to reject a proposed labor agreement with Volvo-owed Mack Trucks late Sunday in a move that will lead to expanded strike action amid the union's weeks-long dispute with the Big 3 automakers. The UAW said a tentative agreement, reached last week between representatives and Mack Trucks management, which included a 19% pay increase and a $3,500 dollar ratification bonus, was rejected by around 73% of the 4,000 union members working for the company across three U.S. states. "We clearly demonstrated our commitment to good faith bargaining by arriving at a tentative agreement that was endorsed by both the International UAW and the UAW Mack Truck Council," said Mac Trucks CEO Stephen Roy. The union said strikes will begin in Maryland, Pennsylvania and Florida at 7:00 am eastern time Monday as a result. "I'm inspired to see UAW members at Mack holding out for a better deal, and ready to stand up and walk off the job to win it," UAW President Shawn Fain said in a statement on the social media website X late Sunday. Meanwhile, the UAW's ongoing action against Ford Motor Company (F) - Get Free Report, General Motors (GM) - Get Free Report and Jeep-maker Stellantis (STLA) - Get Free Report enters its fourth week Monday, with some 25,000 members on strike and picking at plants across eight U.S. states. Talks between Fain and the so-called Big 3, however, appear to be showing some signs of progress, with Ford reportedly offering a pay deal that equates to a 30% increase for UAW members and Fain declining to expand strike activity late last week owing to new concessions from General Motors that could see workers at its joint-venture battery plant with Samsung SDI in Indiana covered by union agreements. The UAW is seeking a 40% pay increase, spread over 4 and a half years, as well as the re-introduction of cost-of-living adjustments, defined benefits pensions and the end to pay tiering for newly-hired workers. Ford shares were marked 1% lower in pre-market trading to indicate an opening bell price of $11.88 each while General Motors fell 1.26% to $30.51 each. Stellantis was down 0.1% in earl Milan trading.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/uaw-rejects-pay-deal-with-mack-trucks-as-big-3-strike-enter-fourth-week)
UAW rejects pay deal with Mack Trucks as Big 3 strike enter fourth week

United Autoworkers Union members voted to reject a proposed labor agreement with Volvo-owed Mack Trucks late Sunday in a move that will lead to expanded strike action amid the union's weeks-long dispute with the Big 3 automakers. The UAW said a tentative agreement, reached last week between representatives and Mack Trucks management, which included a 19% pay increase and a $3,500 dollar ratification bonus, was rejected by around 73% of the 4,000 union members working for the company across three U.S. states. "We clearly demonstrated our commitment to good faith bargaining by arriving at a tentative agreement that was endorsed by both the International UAW and the UAW Mack Truck Council," said Mac Trucks CEO Stephen Roy. The union said strikes will begin in Maryland, Pennsylvania and Florida at 7:00 am eastern time Monday as a result. "I'm inspired to see UAW members at Mack holding out for a better deal, and ready to stand up and walk off the job to win it," UAW President Shawn Fain said in a statement on the social media website X late Sunday. Meanwhile, the UAW's ongoing action against Ford Motor Company (F) - Get Free Report, General Motors (GM) - Get Free Report and Jeep-maker Stellantis (STLA) - Get Free Report enters its fourth week Monday, with some 25,000 members on strike and picking at plants across eight U.S. states. Talks between Fain and the so-called Big 3, however, appear to be showing some signs of progress, with Ford reportedly offering a pay deal that equates to a 30% increase for UAW members and Fain declining to expand strike activity late last week owing to new concessions from General Motors that could see workers at its joint-venture battery plant with Samsung SDI in Indiana covered by union agreements. The UAW is seeking a 40% pay increase, spread over 4 and a half years, as well as the re-introduction of cost-of-living adjustments, defined benefits pensions and the end to pay tiering for newly-hired workers. Ford shares were marked 1% lower in pre-market trading to indicate an opening bell price of $11.88 each while General Motors fell 1.26% to $30.51 each. Stellantis was down 0.1% in earl Milan trading.Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
*Bristol Myers to buy cancer specialists Mirati Therapeutics for $5.8 billion*

Bristol Myers Squibb (BMY) - Get Free Report is set to buy cancer drug specialists Mirati Therapeutics (MRTX) - Get Free Report in a $5.8 billion dollar all-cash deal that adds to a string of recent acquisitions in the oncology sector. Bristol Myers will pay $58 per share for San Diego, California-based Mirati, a 3.65% discount to its Friday closing price and representing a market value of $4.8 billion. Mirati shareholders will also get share rights worth $12 each, worth another $1 billion, if it reaches certain performance milestones. Mrati's most-valuable asset, in terms of near-term cash generation, is likely its recently approved lung cancer treatment. Krazati, which will provide an immediate boost to Bristol Myers' oncology division. Last year, Bristol Myers paid around $4.1 billion for another San Diego-based oncology group, Turning Point Therapeutics, which focuses on oncogenesis, or the process in which healthy cells turn cancerous. β€œWe are excited to add these assets to our portfolio and to accelerate their development as we seek to deliver more treatments for cancer patients,” said Bristol Myers CEO Giovanni Caforio. β€œWith a strong strategic fit, great science and clear value creation opportunities for our shareholders, the Mirati transaction is aligned with our business development goals. Importantly, by leveraging our skills and capabilities, including our global commercial infrastructure, we will ensure patients globally can benefit from Mirati’s portfolio of innovative medicines.” Mirati shares were marked 2.18% lower in pre-market trading to indicate an opening bell price of $58.89 each while Bristol Myers slipped 0.28% to $56.50 each. Earlier this week, pharma rival Eli Lilly ELI said it would pay $1.4 billion for radiation-therapies expert Point Biopharma PNT , another deal that adds to its adds to its growing oncology portfolio, which was jump-started in 2019 with the $8 billion takeover of cancer treatment specialists Loxo OncologyGet investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/bristol-myers-to-buy-cancer-specialists-mirati-therapeutics-for-5-8-billion)
Bristol Myers to buy cancer specialists Mirati Therapeutics for $5.8 billion

Bristol Myers Squibb (BMY) - Get Free Report is set to buy cancer drug specialists Mirati Therapeutics (MRTX) - Get Free Report in a $5.8 billion dollar all-cash deal that adds to a string of recent acquisitions in the oncology sector. Bristol Myers will pay $58 per share for San Diego, California-based Mirati, a 3.65% discount to its Friday closing price and representing a market value of $4.8 billion. Mirati shareholders will also get share rights worth $12 each, worth another $1 billion, if it reaches certain performance milestones. Mrati's most-valuable asset, in terms of near-term cash generation, is likely its recently approved lung cancer treatment. Krazati, which will provide an immediate boost to Bristol Myers' oncology division. Last year, Bristol Myers paid around $4.1 billion for another San Diego-based oncology group, Turning Point Therapeutics, which focuses on oncogenesis, or the process in which healthy cells turn cancerous. β€œWe are excited to add these assets to our portfolio and to accelerate their development as we seek to deliver more treatments for cancer patients,” said Bristol Myers CEO Giovanni Caforio. β€œWith a strong strategic fit, great science and clear value creation opportunities for our shareholders, the Mirati transaction is aligned with our business development goals. Importantly, by leveraging our skills and capabilities, including our global commercial infrastructure, we will ensure patients globally can benefit from Mirati’s portfolio of innovative medicines.” Mirati shares were marked 2.18% lower in pre-market trading to indicate an opening bell price of $58.89 each while Bristol Myers slipped 0.28% to $56.50 each. Earlier this week, pharma rival Eli Lilly ELI said it would pay $1.4 billion for radiation-therapies expert Point Biopharma PNT , another deal that adds to its adds to its growing oncology portfolio, which was jump-started in 2019 with the $8 billion takeover of cancer treatment specialists Loxo OncologyGet investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
*Oil surges as Iran links to Israel attacks add to supply hit concerns*

Updated at 8:07 am EDT Global oil prices surged higher Monday, reversing the market's sharp declines last week, following a series of attacks on Israel from Hamas fighters in the south from Gaza and Hezbollah-backed militants in the north from Lebanon. The surprise moves, which triggered retaliation from Israel and threaten to escalate into a wider regional conflict over the coming weeks, could put as much as 20% of global oil output at risk if it were to expand into the key transit areas around the Strait of Hormuz. Talks between the U.S., Israel and Saudi Arabia, meanwhile, aimed at normalizing relations between the middle east region's two major powers, have also been put on hold and could scupper a reported agreement that would have seen Riyadh reverse some of its current production cuts early next years in return for political cooperation. "Israel is a very marginal oil producer, and so recent developments will have little direct impact on oil supply," said ING commodities analyst Warren Patterson. "However, given the rising tension in the region and the risk that the conflict could spread, market participants will remain nervous until there is a clear de-escalation." "While oil fundamentals have not changed since these attacks, it does not mean they won’t. There are reports that Iran helped Hamas plan the attacks and gave them the "green light'," he added. "If this is proven to be true, we could see the US, an ally of Israel, taking a tougher stance against Iran, which could ultimately lead to a reduction in oil supply." Brent crude futures for December delivery, the global pricing benchmark, were last marked $3.23 higher on the session at $87.80 per barrel. WTI futures for November, which are tightly-linked to U.S. gasoline prices, were marked $3.28 higher at $86.07 per barrel. The moves also partly reversed some of last week's sharp declines, pegged to a projected slump in global demand, which saw both Brent and U.S. crude prices fall the most since March of this year. Post Covid weakness in China, the world's biggest energy importer, as well as a looming recession in Europe and an expected slowdown in driving demand in the U.S. have combined to pull global oil prices lower over the past month. The weekend conflict, however, could keep prices elevated for weeks, or possibly longer, as Israel vows to defend its borders and shutdown militant operations in Gaza and Lebanon. "There is no doubt for us that the next month or two will see increased focus on the Middle East and the consequences of the situation for energy, politics and especially the dire situation for civilians on both sides," said Saxo Bank's chief investment officer Steen Jakobsen. "Markets are concerned about the scale of not only operations in Israel’s immediate neighborhood in the Palestinian territories and Lebanon, but also the risk of escalation with Iran due to its sponsorship of forces hostile to Israel," he added. "Hence the focus will be on anything Iranian: new political initiatives, sanctions and risk of retaliation on Iran’s infrastructure."Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stocks/oil-prices-leap-as-iran-links-to-israel-attacks-add-to-supply-concerns)
Oil surges as Iran links to Israel attacks add to supply hit concerns

Updated at 8:07 am EDT Global oil prices surged higher Monday, reversing the market's sharp declines last week, following a series of attacks on Israel from Hamas fighters in the south from Gaza and Hezbollah-backed militants in the north from Lebanon. The surprise moves, which triggered retaliation from Israel and threaten to escalate into a wider regional conflict over the coming weeks, could put as much as 20% of global oil output at risk if it were to expand into the key transit areas around the Strait of Hormuz. Talks between the U.S., Israel and Saudi Arabia, meanwhile, aimed at normalizing relations between the middle east region's two major powers, have also been put on hold and could scupper a reported agreement that would have seen Riyadh reverse some of its current production cuts early next years in return for political cooperation. "Israel is a very marginal oil producer, and so recent developments will have little direct impact on oil supply," said ING commodities analyst Warren Patterson. "However, given the rising tension in the region and the risk that the conflict could spread, market participants will remain nervous until there is a clear de-escalation." "While oil fundamentals have not changed since these attacks, it does not mean they won’t. There are reports that Iran helped Hamas plan the attacks and gave them the "green light'," he added. "If this is proven to be true, we could see the US, an ally of Israel, taking a tougher stance against Iran, which could ultimately lead to a reduction in oil supply." Brent crude futures for December delivery, the global pricing benchmark, were last marked $3.23 higher on the session at $87.80 per barrel. WTI futures for November, which are tightly-linked to U.S. gasoline prices, were marked $3.28 higher at $86.07 per barrel. The moves also partly reversed some of last week's sharp declines, pegged to a projected slump in global demand, which saw both Brent and U.S. crude prices fall the most since March of this year. Post Covid weakness in China, the world's biggest energy importer, as well as a looming recession in Europe and an expected slowdown in driving demand in the U.S. have combined to pull global oil prices lower over the past month. The weekend conflict, however, could keep prices elevated for weeks, or possibly longer, as Israel vows to defend its borders and shutdown militant operations in Gaza and Lebanon. "There is no doubt for us that the next month or two will see increased focus on the Middle East and the consequences of the situation for energy, politics and especially the dire situation for civilians on both sides," said Saxo Bank's chief investment officer Steen Jakobsen. "Markets are concerned about the scale of not only operations in Israel’s immediate neighborhood in the Palestinian territories and Lebanon, but also the risk of escalation with Iran due to its sponsorship of forces hostile to Israel," he added. "Hence the focus will be on anything Iranian: new political initiatives, sanctions and risk of retaliation on Iran’s infrastructure."Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
*Stocks slump, oil surges, Bristol Myers-Mirati deal, UAW Mack Truck strikes, Peltz eyes Disney seat - 5 Things To Know*

Five things you need to know before the market opens on Monday October 9:1. -- Stock Market Today: Stocks slide, oil surges as attacks on Israel rattle global markets The deadliest attacks on Israel in at least five decades has sent oil prices surging and puts global markets on edge heading into a key week on Wall Street.2. -- Oil prices leap as Iran links to Israel attacks add to supply hit concerns Iran's links to Hamas and Hezbollah, the groups responsible for the deadliest attacks on Israel in decades, has sent global oil prices surging over concerns of a region-wide conflict.3. -- Bristol Myers to buy cancer specialists Mirati Therapeutics for $5.8 billion Bristol Myers will pay up to $5.8 billion for cancer treatment specialists Mirati Therapeutics in the last oncology deal in the fast-moving pharma sector.4. -- UAW rejects pay deal with Mack Trucks as Big 3 strike enter fourth week The United Autoworkers Union, which is entering its fourth week of strike action against the Big 3 automakers, rejected a tentative pay deal with Volvo-owned Mack Trucks late Sunday.5. -- Disney climbs on report Nelson Peltz has boosted stake, seeks board seat Billionaire investor Nelson Peltz, who has been pushing for a seat on Disney's board since late last year, has amassed a $30 billion stake in the media and entertainment group, according to the Wall Street Journal.
[Read more...](https://www.thestreet.com/investing/stocks/stocks-lower-oil-surges-bristol-myers-mirati-uaw-strikes-disney)
Stocks slump, oil surges, Bristol Myers-Mirati deal, UAW Mack Truck strikes, Peltz eyes Disney seat - 5 Things To Know

Five things you need to know before the market opens on Monday October 9:1. -- Stock Market Today: Stocks slide, oil surges as attacks on Israel rattle global markets The deadliest attacks on Israel in at least five decades has sent oil prices surging and puts global markets on edge heading into a key week on Wall Street.2. -- Oil prices leap as Iran links to Israel attacks add to supply hit concerns Iran's links to Hamas and Hezbollah, the groups responsible for the deadliest attacks on Israel in decades, has sent global oil prices surging over concerns of a region-wide conflict.3. -- Bristol Myers to buy cancer specialists Mirati Therapeutics for $5.8 billion Bristol Myers will pay up to $5.8 billion for cancer treatment specialists Mirati Therapeutics in the last oncology deal in the fast-moving pharma sector.4. -- UAW rejects pay deal with Mack Trucks as Big 3 strike enter fourth week The United Autoworkers Union, which is entering its fourth week of strike action against the Big 3 automakers, rejected a tentative pay deal with Volvo-owned Mack Trucks late Sunday.5. -- Disney climbs on report Nelson Peltz has boosted stake, seeks board seat Billionaire investor Nelson Peltz, who has been pushing for a seat on Disney's board since late last year, has amassed a $30 billion stake in the media and entertainment group, according to the Wall Street Journal.
Read more...
*6 свСтовых Π±ΡƒΠ΄ΠΈΠ»ΡŒΠ½ΠΈΠΊΠΎΠ² для Π±ΠΎΠ΄Ρ€ΠΎΠ³ΠΎ ΡƒΡ‚Ρ€Π°*

Π£ Ρ‚ΠΎΠ³ΠΎ, ΠΊΠ°ΠΊ Ρ€Π°Π±ΠΎΡ‚Π°Π΅Ρ‚ Β«ΠΊΠΎΠΌΠ½Π°Ρ‚Π½ΠΎΠ΅ солнцС», Π΅ΡΡ‚ΡŒ Π΄Π°ΠΆΠ΅ Π½Π°ΡƒΡ‡Π½ΠΎΠ΅ объяснСниС.
[Read more...](https://burninghut.ru/svetovye-budilniki/?utm_source=lifehacker.ru&utm_medium=referral&utm_campaign=teaser&utm_content=svetovye-budilniki)
*Samsung прСдставила Π±ΡŽΠ΄ΠΆΠ΅Ρ‚Π½Ρ‹Π΅ ΠΏΠ»Π°Π½ΡˆΠ΅Ρ‚Ρ‹ Galaxy Tab A9 ΠΈ Tab A9+*

ОбновлСниС извСстной сСрии Π½Π΅Π΄ΠΎΡ€ΠΎΠ³ΠΈΡ… ΠΈ сбалансированных устройств.
[Read more...](https://lifehacker.ru/samsung-predstavila-galaxy-tab-a9/)